241 filings
Page 4 of 13
8-K
5iv217f1bnywnhmfic
15 Feb 22
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
jemir3
20 Dec 21
Departure of Directors or Certain Officers
8:00am
8-K
vore3t2h5ksny2 e80
22 Nov 21
Regulation FD Disclosure
8:42am
8-K
h0u9wp8fqjtscju8
3 Nov 21
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
pkdpi
14 Oct 21
CRISPR Therapeutics Announces Transition of Chief Financial Officer
7:15am
8-K
1ea39c
12 Oct 21
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed
4:46pm
S-3ASR
u4ft e2hgejk6r9voss8
29 Jul 21
Automatic shelf registration
5:17pm
8-K
38b4e3nu28
29 Jul 21
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
4:34pm
8-K
38o7a9mffi7
14 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:52pm
8-K
a78h 8sjckm
11 Jun 21
Regulation FD Disclosure
7:10am
8-K
qysrkekc5
2 Jun 21
Other Events
9:16am
DEFA14A
b872 a1qnguotia
28 Apr 21
Additional proxy soliciting materials
4:22pm
8-K
9rco229 h6n0jf
27 Apr 21
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
4:05pm
8-K
yca7seqchxg2l
20 Apr 21
Entry into a Material Definitive Agreement
7:22am
8-K
ta4dwos3f2jk63br0ai
16 Feb 21
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm